BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 8561467)

  • 1. New mechanisms of drug resistance in parasitic protozoa.
    Borst P; Ouellette M
    Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nitric oxide and anti-protozoan chemotherapy].
    Gradoni L; Ascenzi P
    Parassitologia; 2004 Jun; 46(1-2):101-3. PubMed ID: 15305696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
    Hammarton TC; Mottram JC; Doerig C
    Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DHFR in parasitic protozoa.
    Anderson AC
    Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABC transporters and drug resistance in parasitic protozoa.
    Klokouzas A; Shahi S; Hladky SB; Barrand MA; van Veen HW
    Int J Antimicrob Agents; 2003 Sep; 22(3):301-17. PubMed ID: 13678838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.
    Harder A; Greif G; Haberkorn A
    Parasitol Res; 2001 Sep; 87(9):785-6. PubMed ID: 11570567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
    Biñas M; Johnson AM
    Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporter genes facilitating discovery of drugs targeting protozoan parasites.
    Dube A; Gupta R; Singh N
    Trends Parasitol; 2009 Sep; 25(9):432-9. PubMed ID: 19720564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors.
    Rodrigues JC; de Souza W
    Curr Pharm Des; 2008; 14(9):925-38. PubMed ID: 18473841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance and ABC transporters in parasitic protozoa.
    Ouellette M; Légaré D; Papadopoulou B
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):201-6. PubMed ID: 11321574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
    Sen N; Majumder HK
    Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
    Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
    Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
    Reguera RM; Tekwani BL; Balaña-Fouce R
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New drugs for the treatment of human parasitic protozoa].
    Dupouy-Camet J
    Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding drug resistance in human intestinal protozoa.
    El-Taweel HA
    Parasitol Res; 2015 May; 114(5):1647-59. PubMed ID: 25782683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting polyamines of parasitic protozoa in chemotherapy.
    Müller S; Coombs GH; Walter RD
    Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinases as targets for anti-parasitic chemotherapy.
    Doerig C
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):155-68. PubMed ID: 15023358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
    Carter NS; Fairlamb AH
    Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitizers in drug transport mechanisms involved in protozoan resistance.
    Pradines B; Pagès JM; Barbe J
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):411-31. PubMed ID: 16535862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.